Targeting mdm4 as a novel therapeutic approach in prostate cancer independent of p53 status

HIGHLIGHTS

• who: Javier Octavio Mejía-Hernández et al. from the Peter MacCallum Cancer Centre, Grattan St, Melbourne, VIC, Australia Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia have published the Article: Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status, in the Journal: (JOURNAL)
• what: MDM4 may provide a more attractive therapeutic target for the following reasons. The authors examined the role of MDM4 in PC and unveiled the therapeutic potential of targeting MDM4 to treat lethal PCs, either encoding wt or mutant p53 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.